Skip to main content
School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
  • Education
    • Degree Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory
  • School of Medicine Home
  • Departments
  • Department of Medicine
  • Divisions
  • Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine
  • Pulmonary, Allergy, Critical Care, and Sleep Medicine Research
  • Emory Program in Critical Care
  • HIV Disease, Sepsis, and Lung Host Immunity

HIV Disease, Sepsis, and Lung Host Immunity

Emory Program in Critical Care
  • Epidemiology and Health Services Research in Critical Care
  • Structure, Process, and Outcome in Critical Care
  • Fluid Management in Acute Lung Injury
  • Diabetes and Acute Lung Injury
  • The Intersection of Sepsis and Cancer
  • Forecasting Sepsis Progression and Outcomes Using Predictive Analytics
  • HIV Disease, Sepsis, and Lung Host Immunity
  • Stem Cells in Sepsis and Acute Lung Injury
  • Vitamin D in Critically Ill Patients
  • Patient-Centered Outcomes in Critical Care
  • Pre-Hospital Identification and Management of Sepsis
  • Vitamin C for Treatment of Sepsis ARDS
  • Venous Thromboembolic Disease
  • Chronic Alcohol Abuse in Critical Care
HIV and Sepsis

Acute lung disease is a leading cause of death in individuals infected with HIV despite highly active anti-retroviral therapy (HAART). In addition, acute respiratory distress syndrome (ARDS) persists as a significant challenge to critical care physicians. Premature immune senescence or “aging of the immune system” increases the risk of pneumonia in HIV, and despite the fact that pneumonia is a leading cause of ALI/ARDS, there is little known of HIV-1 infection and the risk of ALI/ARDS. 

Sushma Cribbs, MD; Jenny Han, MD; and David Guidot, MD have been interested in the pathobiologic mechanisms underlying HIV immune dysfunction in the lung. There is significant evidence to suggest that phagocytosis and other innate immune functions are impaired in experimental animal models of HIV-1, thereby increasing the risk of lung infection. At Emory University, our group has examined granulocyte-macrophage colony stimulating factor (GM-CSF) in animal models of HIV and found that not only is GM-CSF essential for alveolar macrophage (AM) function and maturation, but chronic HIV infection results in alterations in GM-CSF receptor (GM-CSFr) expression. If shown to be the case in human models as well, strategies to improve these molecular mechanisms could be effective therapies to enhance pulmonary host defense in the setting of ALI.

Additionally, there is compelling evidence that immune function is highly dependent on adequate levels of zinc (Zn), and dietary Zn supplementation can enhance host defenses in the airway. Our group at Emory University, including Dr. Pratibha Joshi, has found that Zn levels in HIV-1 transgenic rats are significantly lower when compared to levels in wild-type rats. In addition, pharmacological induction of Zn deficiency causes defects in AM GM-CSFrβ expression and phagocytosis, resembling defects that were seen in animal models of HIV. Furthermore, Zn supplementation increases intracellular Zn levels, intracellular GM-CSFrβ expression and bacterial phagocytic function, comparable to those for wild-type AM. This evidence suggests that Zn bioavailability in the airway modulates immune function and antioxidant defenses in AMs, and that Zn supplementation maybe a novel strategy to help protect against microbial infections in individuals with HIV and respiratory failure, thus improving outcomes in patients with ALI/ARDS.

Currently, Sushma Cribbs, MD and others have clinical trials underway to prospectively determine the relationship between HIV and the development of ALI by examining the immunostimulatory role of Zn and markers of AM function in ALI patients with and without HIV. Additionally, we are evaluating the efficacy of Zn supplementation to improve Zn levels and AM function in ALI patients with and without HIV.


Emory Program in Critical Care
  • Epidemiology and Health Services Research in Critical Care
  • Structure, Process, and Outcome in Critical Care
  • Fluid Management in Acute Lung Injury
  • Diabetes and Acute Lung Injury
  • The Intersection of Sepsis and Cancer
  • Forecasting Sepsis Progression and Outcomes Using Predictive Analytics
  • HIV Disease, Sepsis, and Lung Host Immunity
  • Stem Cells in Sepsis and Acute Lung Injury
  • Vitamin D in Critically Ill Patients
  • Patient-Centered Outcomes in Critical Care
  • Pre-Hospital Identification and Management of Sepsis
  • Vitamin C for Treatment of Sepsis ARDS
  • Venous Thromboembolic Disease
  • Chronic Alcohol Abuse in Critical Care
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2018 Emory School of Medicine
  • Privacy Policy
  • Emergency Information